Results 61 to 70 of about 14,984 (246)
Regulatory Challenges of Integrating Psychedelics into Mental Health Sector
PsychoactivesPsychedelic substances have recently emerged as a promising method for treating mental health conditions, despite a history of stigmatization and restriction in use.
Kerem Kemal Soylemez +2 more
doaj +1 more source
Changes over time in hallucinogen‐related emergency department visits in Ontario, Canada
Addiction, EarlyView.Abstract Background and aims Recent increasing interest in hallucinogens has underscored the critical gaps in our understanding of their adverse health effects and healthcare usage over time. The current study aimed to examine changes in emergency department (ED) visit rates involving hallucinogens, clinical outcomes of visits and the characteristics ...
Daniel T. Myran +9 more
wiley +1 more source
Entheogens in Christian Art: Wasson, Allegro and the Psychedelic Gospels [PDF]
, 2019 In light of new historical evidence regarding ethnomycologist R. Gordon Wasson’s correspondence with art historian Erwin Panofsky, this article provides an in-depth analysis of the presence of entheogenic mushroom images in Christian art within the ...
Brown, Jerry, Brown, Julie M.
core
Taking Psychedelics Seriously [PDF]
Journal of Palliative Medicine, 2018 Psychiatric research in the 1950s and 1960s showed potential for psychedelic medications to markedly alleviate depression and suffering associated with terminal illness. More recent published studies have demonstrated the safety and efficacy of psilocybin, MDMA, and ketamine when administered in a medically supervised and monitored approach.
openaire +2 more sources
Psychedelics in the treatment of unipolar and bipolar depression
International Journal of Bipolar Disorders, 2022 This is a narrative review about the role of classic and two atypical psychedelics in the treatment of unipolar and bipolar depression. Since the 1990s, psychedelics experience a renaissance in biomedical research.
Oliver G. Bosch +2 more
doaj +1 more source
Addiction, EarlyView.Abstract Background and aims Australia recently down‐scheduled and authorised psychedelic‐assisted therapies, including psilocybin, for certain mental health conditions. Evidence is emerging for potential application in substance use disorder treatment. However, regulatory developments have outpaced implementation readiness.
Sarah J. Catchlove +3 more
wiley +1 more source
Scientific ReportsClassic psychedelics and MDMA have a colorful history of recreational use, and both have recently been re-evaluated as tools for the treatment of psychiatric disorders.
Lukas A. Basedow +5 more
doaj +1 more source
Breaking Out of One’s Head (& Awakening to the World) [PDF]
, 2019 Herein, I review the shattering moment in my life when I awoke from the dream of self to find being as part of the living world and not in my head, discovering my perspectival center to be literally everywhere.
Nixon, Gregory
core
The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network [PDF]
, 2015 The experiences induced by psychedelics share a wide variety of subjective features, related to the complex changes in perception and cognition induced by this class of drugs. A remarkable increase in introspection is at the core of these altered states
Andrade, Katia C. +7 more
core +6 more sources
Doctor or drug dealer? International legal provisions for the legitimate handling of drugs of abuse [PDF]
, 2020 © The Author(s) 2020. The final, definitive version of this paper has been published in: Gallagher, C. T., Atik, S. K., Isse, L., & Mann, S. K. (2020). Doctor or drug dealer?
Atik, Sanaa +3 more
core +2 more sources